rupt the swine galctosyl-transferase gene via homoloIntroduction of the b-D-mannoside b-1,4-N-acetyl-gous recombination (3, 4) . However, gene targeting by glucosaminyltransferase III (GnT-III) gene into swine homologous recombination (3, 4) . However, gene tarendothelial cells (SEC) reduced their susceptibility to geting by homologous recombination in embryonic stem normal human serum (NHS) in complement-mediated cells is not feasible because swine embryonic stem cells cell lysis and also suppressed the antigenicity to hu-are not currently available.
man natural antibodies as evidenced by flow cytome-
Another strategy is to downregulate the a-galactotric analysis, as well as Griffonia simplicifolia 1 isolec-syl epitope by taking advantage of intracellular com- 1,2 FT, we focused on the N-linked sugars which express a high level of antigenicity. We modified this antigenicity, using GnT-III (9,10). Our strategy to diminish the antigenicity of swine cells is directed, not only at Xenotransplantation offers a potential solution to the the a-galactosyl epitope, but to other unknown epiworld-wide shortage of organs for transplantation. topes, but to other unknown epitopes, as well. Since Galili, et al. reported that the a-galactosyl epitope is the major antigen in swine to human xenotrans-METHODS plantation, genetic approaches to modify the glycoantigen have been focused on the xenotransplantation Endothelial cell cultures. A SEC line, MYP30, was cultured in study (1, 2) . One possible approach for the elimination DMEM containing 10% FBS with L-glutamine and penicillin/streptoof the a-galactosyl epitope from swine tissue is to dis-mycin (Gibco/BRL) (11).
Establishment of GnT-III and a1,2FT transfectants. The cDNA of a human GnT-III, Act 5, which contains the entire coding sequence 1 To whom correspondence should be addressed. Fax: -81-6-879-8069. E-mail: miyagawa@orgtrp.med.osaka-u.ac.jp. and deleted at the 5 noncoding region, was subcloned into the site of pCXN2 (12) ; the b-actin promoter and cytomegalovirus enhancer, Abbreviations used: GnT-III, b-D-mannoside b-1,4-N-acetylglucosaminyltransferase III; SEC, swine endothelial cells; NHS, normal with a neomycin-resistant gene. cDNA of human a 1,2 FT, a gift from Dr. John B. Lowe (University of Michigan), was also subcloned human serum; 1B4, Griffonia simplicifolia 1; the a-galactosyl epitope, the Gal a1-3 Gal b 1-4 GlcNAc-R; a 1,2 FT, a 1,2 fucosyltrans-into pCXN2. The plasmids were separately transformed into Escherichia coli C600 and amplified using standard techniques. The ferase; GnT-IV, a-3-D-mannoside b-1,4-N-acetylglucosaminyltransferase IV; GnT-V, a-6-D-mannoside b-1,6 N-acetylglucosaminyltransfer-cDNAs were introduced into MYP-30 by lipid-mediated DNA transfection with lipofectamine (LIPOFECTAMINE Reagent, GIBCO/ ase V; Gal-T, b-1,4 N-galactosyltransferase; UEA-1, Ulex europaeus agglutinin; the H-substance, fucosylated N-acetyl lactosamine; LDH, BRL). Transfected MYP-30 was maintained in complete medium for several days in an atmosphere of humidified 5% CO 2 at 37ЊC. The lactate dehydrogenase; GlcNAc, N-acetylglucosamine.
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Copyright ᭧ 1997 by Academic Press All rights of reproduction in any form reserved. cells were then transferred to complete medium containing 1.0 mg/ ml G418 (GIBCO/BRL) for selection (13) . The expression of plasmids was confirmed by flow cytometry as described below.
Enzyme activity. The enzyme activities of GnT-III, a-3-D-mannoside b-1,4-N-acetylglucosaminyltransferase IV (GnT-IV), a-6-Dmannoside b-1,6 N-acetylglucosaminyltransferase V (GnT-V), and b-1,4 N-galactosyltransferase(Gal-T) in each cell line were first assayed by HPLC as described in earlier reports (14,15). These were determined from the fluorescence intensities, using a pyridylaminated biantennary sugar chain as a substrate.
Reagents. Ulex europaeus agglutinin (UEA-1) or 1B 4 which binds fucosylated N-acetyl lactosamine (the H-substance) or the a-galactosyl epitope, respectively were obtained from Honen Co. Ltd. (Tokyo, Japan) (16) (17) (18) .
Lactate dehydrogenase(LDH) assay. This assay was performed using a Kyokuto MTX''LDH'' kit according to the manufacturer's recommended protocol. The transfected cells were plated at 2 1 10 4 per well in a 96-well tray 1 day prior to the assay. Fifteen hours later, the plates were incubated with 20% or 40% NHS, diluted in PBS, for 2 hr at 37ЊC and the released LDH was measured. The spontaneous release of LDH activity from target cells was below 5% of the maximal release of LDH activity, as determined by the addition of 2% NP40 (13) . GnT-III, GnT-IV, GnT-V, subjected to 12% SDS/PAGE under reducing conditions using the and Gal-T activities of parental SEC and transfectants. These enmethods of Laemmli (19) and then transferred electrophoretically zyme activities were measured using fluorescence-labeled sugar onto a nitrocellulose membrane (Schleicher & Schuell). The mem-chains as substrates. (B) Flow cytometric profiles of a 1,2 FT transfecbrane was blocked in PBS containing 3% BSA and incubated for 1 tants. The H-substance synthesized by a 1,2 FT was measured using hr with 10% normal human pooled serum. After washing the blots an anti-H monoclonal antibody and UEA-1 lectin, rather than the were incubated with horse radish peroxidase-avidin complex (Vector) usal HPLC procedure. H-epitope expression is clearly increased in and developed using an ECL detection system (Amersham).
both clones, compared with a parental SEC line. a, the mean fluorescence value of each clone. Lectin blots. Parent and transfected cell products were also tested by lectin blot analysis, using 1B 4 . The cell lysate (3 mg) was subjected to 12% SDS/PAGE under reducing conditions and then transferred troduction of the GnT-III gene did not decrease the electrophoretically onto a nitrocellulose membrane (Schleicher & Schuell). The blots were blocked in PBS containing 3% BSA and intrinsic activity of Gal-T (Fig. 1A) . Among these, the incubated for 30 min with biotinylated 1B4 10 mg/ml. relative low expression clone, A-3, and the high expression clone, C-17 were used for this study.
RESULTS
Fluorescence histograms of a1,2 FT transfected SEC. The cDNA of a 1,2FT was inserted into the pCXN2 plasmid in a manner similar to that described above, GnT-III activity of parental SEC and transfected and transfection was also performed in the same man-SEC. An expression vector, Act-5, which carried a huner. Two positive clones were established as controls man GnT-III cDNA under the control of the b-actin for comparison with GnT-III transfectants. Instead of gene promoter in the pCXN2 plasmid was prepared as measuring the a 1,2 FT enzyme activity by HPLC, the described (20) . Transfection was perfomed using lipo-H-substance synthesized by a1,2 FT was measured usfectamine. Four positive clones were established, and ing UEA-1 lectin and anti-H monoclonal antibody by the enzyme activities of the GnT-III, GnT-IV, GnT-V, flow cytometry. The H-epitope and the UEA-1-epitope and Gal-T of these clones were measured using fluolevels were increased in both clones, compared to the rescence-labeled sugar chains as substrates. Parental parental SEC (Fig. 1B) . SEC showed no detectable GnT-III activity but clearly showed GnT-V and Gal-T activities. In four positive LDH assay of GnT-III or a1,2 FT transfected SEC. In initial experiments, the amelioration of complementclones, GnT-III activity was clearly elevated, while in-bodies or to the a-galactosyl epitope were detected between these two transfectants.
Western blot and lectin blot analysis. Western blotting was performed in oder to analyze alterations in reactivity to human natural antibodies and 1B4 in
GnT-III transfectants. Cell membrane glycoproteins from parental SEC and transfectants were separated by electrophoresis in a 12% polyacrylamide gel and transferred onto a nitrocellulose membrane. The membrane was then incubated with 10% of NHS and stained. An evaluation of image analyzer profiles re- two transfectants with respect to the reduction of xenoantigenicity to human natural antibodies (Fig. 4A,B) was negligable.
Lectin blotting of whole-cell lysates, obtained from mediated lysis by the SEC transfectants and the control parental SEC cells was assessed using 20% or 40% NHS which constitutes a source of natural antibody and complement. The percent inhibition of complement-mediated lysis by GnT-III or a1,2 FT transfectants was estimated. The control parental SEC lysis by 20% or 40% NHS was found to be 23.1 { 8.5% or 34.1 { 7.5%, respectively. These data are shown in Figure 2 , with each value expressed as mean {SD of four to six experiments.
The results of the GnT-III transfectants A-3 and C-17 suggest that GnT-III is quite effective in reducing the xenoepitope level of SEC. Approximately 70% inhibition of xenoantigenicity was observed in the high expression SEC transfectant C-17.
Fluorescence histograms of parental SEC, GnT-III transfected SEC and a1,2 FT transfected SEC stained with NHS and 1B4 lectin. The effects of the increased
GnT-III activity in transfected SEC were assessed by the susceptibility of the modified SEC to human natural antibody and 1B4 lectin. Typical flow cytometric histogram of these transfect cells are shown in Figure  3 . Parental SEC (control) and stable transfectants were treated with NHS and anti-human Ig (Fig. 3A) or 1B4 lectin (Fig. 3B) .
While control parental SEC reacted strongly with human natural antibodies in NHS, GnT-III or a1,2 FT, transfected SEC showed a diminished reactivity. The The a-galactosyl epitope was approximately 50 to 70% tal SEC reacted strongly with human natural antibodies in NHS, downregulated both in GnT-III transfectants and a1,2 the xenoantigenicity to human natural antibody was reduced and the FT transfectants. No specific differences in the down-a-galactosyl epitope was also downregulated in both transfectants. a, the mean fluorescence value of each clone.
regulation of xenoantigenicity to human natural anti-
FIG. 4.
Western blot and lectin blot analysis. Parental SEC and transfectant cell membrane glycoproteins (3 mg) were separated by electrophoresis in a 12% polyacrylamide gel and transferred onto a nitrocellulose membrane. The membrane was incubated for 1 hr with 10% of NHS and then stained. After washing, the blots were incubated with horse radish peroxidase-avidin complex and developed using an ECL detection system. Image analyzer profiles were used to evaluate a typical Western blot pattern of IgG (A) and IgM (B). The position markers are indicated at the bottom. Lectin blot analysis of whole-cell lysates from the parental SEC and transfectants was also performed. Cell lysates from SEC, GnT-III, and a 1,2 FT transfectants were separated on a SDS/PAGE and transferred onto a nitrocellulose membrane. The blots were probed with biotinylated 1B4 lectin (10 mg/ml). The position markers are indicated (C).
the parental SEC cell and transfectants was also per-strate specificities of the enzymes, and the localization formed. Cell lysates from these cells were separated on of the enzymes in tissues and organelles. GnT-III catala 12% SDS/PAGE and transferred onto a nitrocellulose yses the branching of N-linked oligosaccharides to promembrane. The blots were probed with 1B4 lectin. Sim-duce a bisecting N-acetylglucosamine (GlcNAc) resiilar to the western blotting, observations proteins, es-due. The attachment of a bisecting GlcNAc inhibits the pecially those with molecular sizes under 66 kDa of further processing of oligosaccharides by other glycoboth transfected cells reduced the reactivity to 1B4, as syltransferases. That is, once a bisecting GlcNAc resicompared to the parental SEC (Fig. 4C) .
due is added to the core mannose by GnT-III, a competitive enzyme; GnT-IV and GnT-V are not able to form any further tri-structure in the Golgi stack (20) (21) (22) .
DISCUSSION
In this study, the introduction of the GnT-III gene did not decrease the intrinsic activity of Gal-T, but deIn the present study, we examined the amelioration creased the level of xenoantigen such as, for example, of antigenicity of N-linked oligosaccharides by the overthe a-galactosyl epitope. Clearly, futher studies will be expression of GnT-III, with the goal of providing a perrequired, in oder to understand and fully explain this manent solution for overcoming hyperacute rejection effect. However, not only a reduction in the number of in clinical xenotransplantation.
branches formed, including b1,6 branches (22) occurs, In general, the regulation of sugar chain biosynthesis is under the control of glycosyltransferases, the sub-but it is also thought that the entire N-linked oligosac-charides are remodeled, as a result of the overex-against the same xeno-epitope on N-linked sugars. Further experiments will be required to examine these pospression of GnT-III (23, 24) .
On the other hand, this bisecting GlcNAc structure sibilities. Moreover, the possibility of synergism between these two different glycosyltransferases, cannot has been found in glycoproteins from a variety of tissues. It is well known that GnT-III is abundant in be excluded.
In conclusion, GnT-III was overexpressed to reduce brain and kidney tissues (25) (26) . Therefore, the products produced as a result of the overexpression of the antigenicity of swine xenoantigen to humans and the effect was assessed using GnT-III transfected SEC GnT-III cannot constitute a new epitope to human natural antibodies.
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detected between the GnT-III transfectants and the a1,2 FT transfectants that showed a high level of enzymatic activity (4, 6) in flow cytometric analysis. REFERENCES Therefore, a Western blot of the GnT-III transfec-
